Lava Therapeutics Nv (LVTX)

$2.02

-0.04

(-1.94%)

Market is closed - opens 7 PM, 23 Jul 2024

Performance

  • $1.92
    $2.10
    $2.02
    downward going graph

    4.95%

    Downside

    Day's Volatility :8.57%

    Upside

    3.81%

    downward going graph
  • $1.13
    $6.47
    $2.02
    downward going graph

    44.06%

    Downside

    52 Weeks Volatility :82.53%

    Upside

    68.78%

    downward going graph

Returns

PeriodLava Therapeutics NvSector (Health Care)Index (Russel 2000)
3 Months
-27.72%
6.0%
0.0%
6 Months
34.64%
5.6%
0.0%
1 Year
11.35%
8.5%
0.0%
3 Years
-77.9%
13.8%
-19.6%

Highlights

Market Capitalization
54.6M
Book Value
$1.93
Earnings Per Share (EPS)
-1.06
Wall Street Target Price
7.25
Profit Margin
-228.02%
Operating Margin TTM
-27.92%
Return On Assets TTM
-16.89%
Return On Equity TTM
-45.4%
Revenue TTM
12.5M
Revenue Per Share TTM
0.47
Quarterly Revenue Growth YOY
471.2%
Gross Profit TTM
-20.7M
EBITDA
-31.0M
Diluted Eps TTM
-1.06
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.18
EPS Estimate Next Year
-1.79
EPS Estimate Current Quarter
-0.12
EPS Estimate Next Quarter
-0.43

Analyst Recommendation

Buy
    90%Buy
    9%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for Lava Therapeutics Nv(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 258.91%

Current $2.02
Target $7.25

Technicals Summary

Sell

Neutral

Buy

Lava Therapeutics Nv is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Lava Therapeutics Nv
Lava Therapeutics Nv
10.16%
34.64%
11.35%
-77.9%
-85.59%
Moderna, Inc.
Moderna, Inc.
-11.58%
21.5%
-1.52%
-62.55%
762.21%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-0.03%
12.81%
46.27%
81.23%
258.69%
Novo Nordisk A/s
Novo Nordisk A/s
-7.55%
24.69%
62.32%
198.21%
443.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.5%
11.69%
37.68%
150.78%
182.38%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Lava Therapeutics Nv
Lava Therapeutics Nv
0.25
NA
NA
-1.18
-0.45
-0.17
NA
1.93
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.53
31.53
1.46
44.41
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.49
45.49
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.66
31.66
0.53
17.05
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Lava Therapeutics Nv
Lava Therapeutics Nv
Buy
$54.6M
-85.59%
0.25
-228.02%
Moderna, Inc.
Moderna, Inc.
Buy
$46.5B
762.21%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.5B
258.69%
31.53
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$589.9B
443.55%
45.49
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.0B
182.38%
31.66
39.46%

Insights on Lava Therapeutics Nv

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 53.0K → 6.99M (in $), with an average increase of 90.0% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 5 quarters, -14.99M → -553.0K (in $), with an average increase of 293.2% per quarter

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 58.8% return, outperforming this stock by 51.5%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 198.2% return, outperforming this stock by 276.1%

Institutional Holdings

  • Redmile Group, LLC

    7.89%
  • Bruce & Co Inc

    2.94%
  • Sphera Funds Management Ltd.

    1.40%
  • Walleye Trading Advisors, LLC

    0.59%
  • Alpha Wave Global LP

    0.41%
  • Two Sigma Investments LLC

    0.31%

Company Information

Organization
Lava Therapeutics Nv
Employees
37
CEO
Mr. Stephen Allen Hurly M.B.A., M.Sc.
Industry
Services

FAQs